Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ebos GroupEBOSF +15.85%85 3-Year Dividend Growth Rate is 8.40% as of Dec. 2025, which is 24% below its 10-year median of 11.05. GuruFocus rates EBOSF with a GF Score™ of 85/100 and a GF Value™ of $43.41. The stock has 4 warning signs investors should review. Among 53 Medical Distribution companies, Ebos Group ranks better than 60.38% on this metric.
The historical rank and industry rank for Ebos Group's 3-Year Dividend Growth Rate or its related term are showing as below:
EBOSF'
s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 5.8 Med: 11.05 Max: 40.4
Current: 8.4
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Ebos Group was 40.40% per year. The lowest was 5.80% per year. And the median was 11.05% per year.
EBOSF's 3-Year Dividend Growth Rate is ranked better than 60.38% of 53
companies
in the Medical Distribution industry
Industry Median: 5.4
vs EBOSF: 8.40
During the past 3 years, the average Dividends Per Share Growth Rate was 8.40% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 10.20% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 10.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Ebos Group Ltd is 0.93, which seems too high.
For more information regarding to dividend, please check our Dividend Page.
Ebos Group (OTCPK:EBOSF) 3-Year Dividend Growth Rate Explanation
1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.
Ebos Group's Dividend Payout Ratio for the quarter that ended in Dec. 2025 is calculated as
During the past 13 years, the highest Dividend Payout Ratio of Ebos Group was 1.01. The lowest was 0.59. And the median was 0.68.
Warning Sign:
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of Ebos Group Ltd is 0.93, which seems too high.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Ebos Group Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
NZD 0.570000
2026-03-05
2026-03-06
2026-03-27
Cash Dividend
semi-annually
NZD:USD 0.600962
NZD 0.615000
2025-09-04
2025-09-05
2025-09-24
Cash Dividend
semi-annually
NZD:USD 0.588235
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Ebos Group's Dividend Yield (%) for Today is calculated as
Current Share Price is $23.75.
Ebos Group's Dividends per Share for the trailing twelve months (TTM) ended in Today is $0.704312865.
During the past 13 years, the highest Dividend Yield of Ebos Group was 6.07%. The lowest was 0.00%. And the median was 2.96%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ebos Group 3-Year Dividend Growth Rate Related Terms>
EBOSF vs MCK, COR, CAH: 3-Year Dividend Growth Rate Comparison
For the Medical Distribution subindustry, Ebos Group's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ebos Group 3-Year Dividend Growth Rate vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Ebos Group's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Ebos Group's 3-Year Dividend Growth Rate falls into.
Ebos Group 3-Year Dividend Growth Rate Calculation
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 8.40% mean?
Ebos Group (EBOSF) has a 3-Year Dividend Growth Rate of 8.40% as of Dec. 2025. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Ebos Group and its competitors. This is 24% below median its historical median of 11.05. Over the past decade, Ebos Group's 3-Year Dividend Growth Rate has ranged from 5.80 to 40.40. According to the industry distribution chart, Ebos Group ranks #21 out of 53 companies in the Medical Distribution industry, placing it in the top 39.6%.
Is Ebos Group's 3-Year Dividend Growth Rate too high?
Ebos Group's current 3-Year Dividend Growth Rate of 8.40% is 24% below median its 10-year median of 11.05. Over the past 10 years, this metric has ranged from a low of 5.80 to a high of 40.40. The Medical Distribution industry median 3-Year Dividend Growth Rate is 5.40. Ebos Group's value of 8.40% is 55.6% above this industry median. Based on the distribution chart, Ebos Group ranks #21 out of 53 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Ebos Group has a GF Score™ of 85/100, reflecting its overall financial health beyond just this single metric.
How does Ebos Group's 3-Year Dividend Growth Rate compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Ebos Group ranks #21 out of 53 companies for 3-Year Dividend Growth Rate. This puts Ebos Group in the upper half of its industry. The industry median 3-Year Dividend Growth Rate is 5.40. Ebos Group's value of 8.40% is 55.6% above this benchmark. Historically, Ebos Group's own 3-Year Dividend Growth Rate has ranged from 5.80 to 40.40 over the past decade. While the company's 10-year median is 11.05 vs. the industry median of 5.40, Ebos Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Medical Distribution company?
The median 3-Year Dividend Growth Rate among Medical Distribution companies is 5.40, based on 53 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ebos Group's current 3-Year Dividend Growth Rate of 8.40% is 55.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Ebos Group and its competitors. For the Medical Distribution industry, the median 3-Year Dividend Growth Rate is 5.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ebos Group's current 3-Year Dividend Growth Rate is 8.40%, which is 24% below median its own 10-year median of 11.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ebos Group stock overvalued right now?
Ebos Group (EBOSF) has a current 3-Year Dividend Growth Rate of 8.40%. The stock's GF Value™ is $43.41, compared to a current price of $23.75 — trading 45.3% below its estimated fair value. The current 3-Year Dividend Growth Rate is 8.40%, which is 24% below median its 10-year median of 11.05 and 55.6% above the Medical Distribution industry median of 5.40. Ebos Group's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Ebos Group (EBOSF), the current 3-Year Dividend Growth Rate is 8.40% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ebos Group (EBOSF) Overvalued in 2026?
Based on GuruFocus' analysis, Ebos Group stock appears to be undervalued.
The current stock price of $23.75 is trading 45.3% below its estimated GF Value™ of $43.41.
Key valuation signals for EBOSF:
3-Year Dividend Growth Rate: 8.40% (24% below median its 10-year median of 11.05)
GF Value™: $43.41 vs. price of $23.75 (45.3% below fair value)
Industry Position: 55.6% above the Medical Distribution median (#21 of 53)
No single metric tells the full story. See the EBOSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ebos is the largest pharmaceutical wholesaler across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 50% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.
85GF Score
Get the complete analysis for EBOSF
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
EBOSF has been successfully added to your 
